Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hyatt

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2003
Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivoAssem-Galal Ziady, Christopher R Gedeon, Timothy Miller, et al.
The Journal of Biological Chemistry|June 17, 2003
Nanoparticles of compacted DNA transfect postmitotic cellsGe Liu, DeShan Li, Murali K Pasumarthy, et al.
Plos One|November 18, 2014
Dual pharmacological targeting of the MAP kinase and PI3K/mTOR pathway in preclinical models of colorectal cancerTodd M Pitts, Timothy P Newton, Erica L Bradshaw-Pierce, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2003
Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lungAssem-Galal Ziady, Christopher R Gedeon, Osman Muhammad, et al.
Frontiers in Pharmacology|July 3, 2015
Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer modelsS Lindsey Davis, Kelli M Robertson, Todd M Pitts, et al.
Human Gene Therapy|February 3, 2005
Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitutionMichael W Konstan, Pamela B Davis, Jeffrey S Wagener, et al.
Oncotarget|July 8, 2016
Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancerTodd M Pitts, Erica L Bradshaw-Pierce, Stacey M Bagby, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2003
Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivoAssem-Galal Ziady, Christopher R Gedeon, Timothy Miller, et al.
The Journal of Biological Chemistry|June 17, 2003
Nanoparticles of compacted DNA transfect postmitotic cellsGe Liu, DeShan Li, Murali K Pasumarthy, et al.
Plos One|November 18, 2014
Dual pharmacological targeting of the MAP kinase and PI3K/mTOR pathway in preclinical models of colorectal cancerTodd M Pitts, Timothy P Newton, Erica L Bradshaw-Pierce, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2003
Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lungAssem-Galal Ziady, Christopher R Gedeon, Osman Muhammad, et al.
Frontiers in Pharmacology|July 3, 2015
Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer modelsS Lindsey Davis, Kelli M Robertson, Todd M Pitts, et al.
Human Gene Therapy|February 3, 2005
Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitutionMichael W Konstan, Pamela B Davis, Jeffrey S Wagener, et al.
Oncotarget|July 8, 2016
Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancerTodd M Pitts, Erica L Bradshaw-Pierce, Stacey M Bagby, et al.
Pageof 6